Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer

PURPOSE: This phase I trial evaluated the question of whether the standard starting dose of axitinib could be administered in combination with therapeutic doses of cisplatin/capecitabine in patients with previously untreated advanced gastric cancer, and assessed overall safety, pharmacokinetics, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Do-Youn, Doi, Toshihiko, Shirao, Kuniaki, Lee, Keun-Wook, Park, Sook Ryun, Chen, Ying, Yang, Liqiang, Valota, Olga, Bang, Yung-Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614203/
https://www.ncbi.nlm.nih.gov/pubmed/25687867
http://dx.doi.org/10.4143/crt.2014.225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614203/
https://www.ncbi.nlm.nih.gov/pubmed/25687867
http://dx.doi.org/10.4143/crt.2014.225

Ejemplares similares